Okanoue T - Search Results

1

Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis-related fibrosis: Multicenter study.

Seko Y, Takahashi H, Toyoda H, Hayashi H, Yamaguchi K, Iwaki M, Yoneda M, Arai T, Shima T, Fujii H, Morishita A, Kawata K, Tomita K, Kawanaka M, Yoshida Y, Ikegami T, Notsumata K, Oeda S, Kamada Y, Sumida Y, Fukushima H, Miyoshi E, Aishima S, Okanoue T, Nakajima A, Itoh Y; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Seko Y, et al. Among authors: okanoue t. Hepatol Res. 2023 Apr;53(4):312-321. doi: 10.1111/hepr.13871. Epub 2023 Jan 10. Hepatol Res. 2023. PMID: 36524984

2

[Autoimmune disorders in interferon therapy].

Okanoue T, Itoh Y, Yasui K. Okanoue T, et al. Nihon Rinsho. 1994 Jul;52(7):1924-8. Nihon Rinsho. 1994. PMID: 7521440 Review. Japanese.

3

Serum autoantibody against interleukin-1 alpha is unrelated to the etiology or activity of liver disease but can be raised by interferon treatment.

Itoh Y, Okanoue T, Sakamoto S, Nishioji K, Kashima K, Ohmoto Y. Itoh Y, et al. Among authors: okanoue t. Am J Gastroenterol. 1995 May;90(5):777-82. Am J Gastroenterol. 1995. PMID: 7733087

4

Serum levels of macrophage colony stimulating factor (M-CSF) in liver disease.

Itoh Y, Okanoue T, Enjyo F, Sakamoto S, Ohmoto Y, Hirai Y, Kagawa K, Kashima K. Itoh Y, et al. Among authors: okanoue t. J Hepatol. 1994 Oct;21(4):527-35. doi: 10.1016/s0168-8278(94)80097-9. J Hepatol. 1994. PMID: 7814798

5

Effects of bile acids and taurine on the lipid fluidity of hepatic microsomes in normal and bile duct-ligated rats--a spin label study.

Nakashima T, Shima T, Sakamoto Y, Nakajima T, Seto Y, Sano A, Iwai M, Okanoue T, Kashima K. Nakashima T, et al. Among authors: okanoue t. J Hepatol. 1993 Apr;18(1):74-9. doi: 10.1016/s0168-8278(05)80012-1. J Hepatol. 1993. PMID: 8393465

6

Role of sinusoidal endothelial cells in liver disease.

Okanoue T, Mori T, Sakamoto S, Itoh Y. Okanoue T, et al. J Gastroenterol Hepatol. 1995;10 Suppl 1:S35-7. doi: 10.1111/j.1440-1746.1995.tb01794.x. J Gastroenterol Hepatol. 1995. PMID: 8589339

7

Circulating HCV-RNA, HCV genotype, and liver histology in asymptomatic individuals reactive for anti-HCV antibody and their follow-up study.

Okanoue T, Yasui K, Sakamoto S, Minami M, Nagao Y, Itoh Y, Kagawa K, Kashima K. Okanoue T, et al. Liver. 1996 Aug;16(4):241-7. doi: 10.1111/j.1600-0676.1996.tb00736.x. Liver. 1996. PMID: 8877994

8

Side effects of high-dose interferon therapy for chronic hepatitis C.

Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M, Nishioji K, Katagishi T, Nakagawa Y, Tada H, Sawa Y, Mizuno M, Kagawa K, Kashima K. Okanoue T, et al. J Hepatol. 1996 Sep;25(3):283-91. doi: 10.1016/s0168-8278(96)80113-9. J Hepatol. 1996. PMID: 8895006

9

The effects of prednisolone and interferons on serum macrophage colony stimulating factor concentrations in chronic hepatitis B.

Itoh Y, Okanoue T, Sakamoto S, Nishioji K, Kashima K. Itoh Y, et al. Among authors: okanoue t. J Hepatol. 1997 Feb;26(2):244-52. doi: 10.1016/s0168-8278(97)80037-2. J Hepatol. 1997. PMID: 9059942

10

Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group.

Okanoue T, Itoh Y, Minami M, Sakamoto S, Yasui K, Sakamoto M, Nishioji K, Murakami Y, Kashima K. Okanoue T, et al. J Hepatol. 1999 Apr;30(4):653-9. doi: 10.1016/s0168-8278(99)80196-2. J Hepatol. 1999. PMID: 10207807 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

468 results

Search Page